ATE503472T1 - Nateglinide-tablettenzubereitungen - Google Patents

Nateglinide-tablettenzubereitungen

Info

Publication number
ATE503472T1
ATE503472T1 AT05014497T AT05014497T ATE503472T1 AT E503472 T1 ATE503472 T1 AT E503472T1 AT 05014497 T AT05014497 T AT 05014497T AT 05014497 T AT05014497 T AT 05014497T AT E503472 T1 ATE503472 T1 AT E503472T1
Authority
AT
Austria
Prior art keywords
meals
tablet preparations
carboxymethyl cellulose
tablet composition
nateglinide tablet
Prior art date
Application number
AT05014497T
Other languages
English (en)
Inventor
Akira Yabuki
Masato Kaida
Takahiko Ando
Nobutaka Ninomiya
Masanao Ozaki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18100283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE503472(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE503472T1 publication Critical patent/ATE503472T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05014497T 1996-11-15 1997-11-14 Nateglinide-tablettenzubereitungen ATE503472T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31854196 1996-11-15

Publications (1)

Publication Number Publication Date
ATE503472T1 true ATE503472T1 (de) 2011-04-15

Family

ID=18100283

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97912459T ATE322260T1 (de) 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform
AT05014497T ATE503472T1 (de) 1996-11-15 1997-11-14 Nateglinide-tablettenzubereitungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97912459T ATE322260T1 (de) 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform

Country Status (14)

Country Link
US (4) US6143323A (de)
EP (3) EP2277517A1 (de)
JP (1) JP4171091B2 (de)
KR (1) KR100343062B1 (de)
CN (1) CN1245158C (de)
AT (2) ATE322260T1 (de)
AU (1) AU718350B2 (de)
CA (1) CA2271865C (de)
DE (2) DE69735644T2 (de)
DK (1) DK1586314T3 (de)
ES (2) ES2257772T3 (de)
PT (2) PT965339E (de)
TW (1) TW492878B (de)
WO (1) WO1998022105A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100343062B1 (ko) * 1996-11-15 2002-07-02 에가시라 구니오 정제 조성물
EP2263660B1 (de) 1998-05-18 2017-09-27 Takeda Pharmaceutical Company Limited Im Munde zerfallende Tablette
DE69942777D1 (de) * 1998-07-28 2010-10-28 Takeda Pharmaceutical Leicht zerfallende feste Zubereitung
JP2000119160A (ja) * 1998-10-06 2000-04-25 Kanebo Ltd 皮膚化粧料
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US6878749B2 (en) 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
ES2248159T3 (es) 1999-12-28 2006-03-16 Ajinomoto Co., Inc. Preparaciones orales para diabetes.
EP1283054A4 (de) * 2000-03-17 2006-04-12 Ajinomoto Kk Medikamente zur behandlung von komplikationen des diabetes und neuropathien, und verwendung davon
WO2002032854A1 (en) * 2000-10-18 2002-04-25 Ajinomoto Co.,Inc. Process for producing nateglinide crystal
ATE373635T1 (de) 2000-10-18 2007-10-15 Ajinomoto Kk Verfahren zur herstellung von acylphenylalaninen
BR0114846A (pt) 2000-10-24 2004-02-25 Ajinomoto Kk Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h
PT1334721E (pt) * 2000-10-24 2009-06-01 Ajinomoto Kk Preparações de fármacos hidrofílicos contendo nateglinida
AU2001295999A1 (en) * 2000-10-24 2002-05-06 Ajinomoto Co., Inc. Nateglinide-containing preparations
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1247194C (zh) * 2002-08-27 2006-03-29 石药集团中奇制药技术（石家庄）有限公司 一种那格列奈包合物
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
WO2005013964A1 (ja) * 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
WO2005016315A1 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
WO2005094812A1 (ja) * 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
WO2005117840A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
JP2008509144A (ja) * 2004-08-04 2008-03-27 アルザ・コーポレーシヨン 上昇するゼロ次放出パターンを示す持続薬剤放出組成物、そのような組成物を製造する方法
KR20070058540A (ko) * 2004-10-01 2007-06-08 니폰 조키 세야쿠 가부시키가이샤 고형 의약제제
US7276198B2 (en) * 2004-12-28 2007-10-02 The Goodyear Tire & Rubber Company Method and mold for making tire with tie bar
JP4974057B2 (ja) * 2005-01-31 2012-07-11 味の素株式会社 血糖降下剤を含有する、耐糖能異常、境界型糖尿病、インスリン抵抗性及び高インスリン血症の改善ないし治療用医薬組成物
JPWO2008072532A1 (ja) * 2006-12-07 2010-03-25 第一三共株式会社 貯蔵安定性が改善された医薬組成物
WO2008072533A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 固形製剤の製造方法
WO2008072535A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
US20100004279A1 (en) * 2006-12-07 2010-01-07 Tomoyuki Watanabe Solid medicinal preparation containing mannitol or lactose
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
DK0526171T3 (da) 1991-07-30 1997-08-25 Ajinomoto Kk Krystaller af N-(trans-4-isopropylcyclohexylcarbonyl)-Dphenylalanin og fremgangsmåder til fremstilling deraf
EP0614358A1 (de) * 1991-11-26 1994-09-14 Warner-Lambert Company Verfahren und zusammensetzung für die entwicklung einer gemfibrozil dosierungsform mit kontrollierter freigabe
KR100343062B1 (ko) * 1996-11-15 2002-07-02 에가시라 구니오 정제 조성물

Also Published As

Publication number Publication date
DE69740161D1 (de) 2011-05-12
JP4171091B2 (ja) 2008-10-22
EP2277517A1 (de) 2011-01-26
ATE322260T1 (de) 2006-04-15
KR100343062B1 (ko) 2002-07-02
US6143323A (en) 2000-11-07
EP0965339B1 (de) 2006-04-05
JPH10194969A (ja) 1998-07-28
EP1586314A1 (de) 2005-10-19
CA2271865A1 (en) 1998-05-28
US6641841B2 (en) 2003-11-04
DE69735644D1 (de) 2006-05-18
WO1998022105A1 (en) 1998-05-28
ES2364145T3 (es) 2011-08-25
DE69735644T2 (de) 2007-05-03
US6296872B1 (en) 2001-10-02
KR20000053312A (ko) 2000-08-25
PT965339E (pt) 2006-06-30
PT1586314E (pt) 2011-07-01
US20030147951A1 (en) 2003-08-07
DK1586314T3 (da) 2011-06-20
EP1586314B1 (de) 2011-03-30
US6844008B2 (en) 2005-01-18
US20020028239A1 (en) 2002-03-07
CN1242704A (zh) 2000-01-26
AU4965497A (en) 1998-06-10
CN1245158C (zh) 2006-03-15
TW492878B (en) 2002-07-01
CA2271865C (en) 2003-10-14
AU718350B2 (en) 2000-04-13
EP0965339A4 (de) 2003-04-23
EP0965339A1 (de) 1999-12-22
ES2257772T3 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
ATE503472T1 (de) Nateglinide-tablettenzubereitungen
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
DK642587D0 (da) Insulinpraeparat
ES2123903T3 (es) Composicion nutritiva conteniendo fibra.
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
NO870772L (no) Vevplasminogenaktivator for normale humane tykktarmceller.
ATE83651T1 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
MX9100246A (es) Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
EP1108429A3 (de) Verbesserte Aminosäurenzusammensetzung zum Bereitstellen von Aminosäurenergänzungen oder Eiweissersatz, insbesondere zur Behandlung und/oder Verwaltung von bestimmten Erkrankungen
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
DK162471C (da) Suge- eller tyggetablet
CN1109357A (zh) 一种美容保健制品及工艺方法
RU94030887A (ru) N-ацетил-дегидрофенилаланил-l-метионин
蕭裕明 et al. Surgical Correction of Pes Cavus and Equinus Deformity in Two Young Adults
RU95105084A (ru) Гепатопротекторное средство природного происхождения
LT2000063A (en) Food additive
MX9603241A (es) Productos farmaceuticos para curar enfermedades tumorales y procedimiento para su preparacion.
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1586314

Country of ref document: EP